Interactions of Shiga-like toxin with human peripheral blood monocytes

被引:25
作者
Geelen, Joyce M. [1 ]
van der Velden, Thea J. A. M. [1 ]
van den Heuvel, Lambertus P. W. J. [1 ]
Monnens, Leo A. H. [1 ]
机构
[1] Univ Nijmegen, Radboud Med Ctr, Dept Paediat Nephrol, NL-6500 HB Nijmegen, Netherlands
关键词
monocyte; hemolytic uremic syndrome; Shiga-like toxin; acute renal failure; HUVEC; vero cells;
D O I
10.1007/s00467-007-0512-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The cytotoxic effect of Shiga-like toxin (Stx; produced by certain Escherichia coli strains) plays a central role in typical hemolytic uremic syndrome (HUS). It damages the renal endothelium by inhibiting the cellular protein synthesis. Also, the monocyte has a specific receptor for Stx but is not sensitive for the cytotoxic effect. In this work, monocytes were studied as a potential transporter for Stx to the renal endothelium. Coincubation of isolated human monocytes loaded with Stx and target cells (vero cells and human umbilical vascular endothelial cells) were performed. Transfer was determined by measuring the protein synthesis of target cells and by flow cytometry. Furthermore, the effect of a temperature shift on loaded monocytes was investigated. Stx-loaded monocytes reduced the protein synthesis of target cells. After adding an antibody against Stx, incomplete recovery occurred. Also, adding only the supernatant of coincubation was followed by protein synthesis inhibition. Stx detached from its receptor on the monocyte after a change in temperature, and no release was detected without this temperature shift. Although the monocyte plays an important role in the pathogenesis of HUS, it has no role in the transfer of Stx.
引用
收藏
页码:1181 / 1187
页数:7
相关论文
共 29 条
[1]   Translocation of Shiga toxin across polarized Intestinal cells in tissue culture [J].
Acheson, DWK ;
Moore, R ;
DeBreucker, S ;
Lincicome, L ;
Jacewicz, M ;
Skutelsky, E ;
Keusch, GT .
INFECTION AND IMMUNITY, 1996, 64 (08) :3294-3300
[2]   Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo:: Therapeutic implications for hemolytic-uremic syndrome [J].
Armstrong, GD ;
Mulvey, GL ;
Marcato, P ;
Griener, TP ;
Kahan, MC ;
Tennent, GA ;
Sabin, CA ;
Chart, H ;
Pepys, MB .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (08) :1120-1124
[3]   A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders [J].
Besbas, N. ;
Karpman, D. ;
Landau, D. ;
Loirat, C. ;
Proesmans, W. ;
Remuzzi, G. ;
Rizzoni, G. ;
Taylor, C. M. ;
Van de Kar, N. ;
Zimmerhackl, L. B. .
KIDNEY INTERNATIONAL, 2006, 70 (03) :423-431
[4]   EVIDENCE THAT VEROTOXINS (SHIGA-LIKE TOXINS) FROM ESCHERICHIA-COLI BIND TO P-BLOOD-GROUP ANTIGENS OF HUMAN ERYTHROCYTES IN-VITRO [J].
BITZAN, M ;
RICHARDSON, S ;
HUANG, C ;
BOYD, B ;
PETRIC, M ;
KARMALI, MA .
INFECTION AND IMMUNITY, 1994, 62 (08) :3337-3347
[5]  
CAMPBELL EJ, 1989, J IMMUNOL, V143, P2961
[6]   Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome [J].
Chaisri, U ;
Nagata, M ;
Kurazono, H ;
Horie, H ;
Tongtawe, P ;
Hayashi, H ;
Watanabe, T ;
Tapchaisri, P ;
Chongsa-nguan, M ;
Chaicumpa, W .
MICROBIAL PATHOGENESIS, 2001, 31 (02) :59-67
[7]  
COHEN A, 1998, INT IMMUNOL, V2, P11
[8]   Shiga toxins activate translational regulation pathways in intestinal epithelial cells [J].
Colpoys, WE ;
Cochran, BH ;
Carducci, TM ;
Thorpe, CM .
CELLULAR SIGNALLING, 2005, 17 (07) :891-899
[9]  
Cooling LLW, 1998, INFECT IMMUN, V66, P4355
[10]   Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells [J].
Creydt, VP ;
Silberstein, C ;
Zotta, E ;
Ibarra, C .
MICROBES AND INFECTION, 2006, 8 (02) :410-419